CIK 0001802768 · Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- (212) 883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,324,753
- in 4 filings, $12.3M under 10b5-1 plans
Net −$12,324,753. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | Hite Christopher EVP & Chairman, Partnering | Grant or award | +7,122 | 277,523 | ||
| 2026-09-22 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −96,073 | $58.51 | $5.6M | 274,328 |
| 2026-09-22 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −3,927 | $58.93 | $231K | 270,401 |
| 2026-08-19 | Hite Christopher EVP & Chairman, Partnering | Gift 10b5-1 | −16,800 | 23,200 | ||
| 2026-08-18 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −100,000 | $59.97 | $6.0M | 370,401 |
| 2026-08-05 | Hite Christopher EVP & Chairman, Partnering | Grant or award | +11,002 | 470,401 | ||
| 2026-06-30 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −97,446 | $56.50 | $5.5M | 461,953 |
| 2026-06-30 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −2,554 | $57.10 | $146K | 459,399 |
| 2026-06-30 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −29,400 | $56.44 | $1.7M | 40,600 |
| 2026-06-30 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −600 | $57.09 | $34K | 40,000 |
| 2026-06-23 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −32,408 | $54.11 | $1.8M | 676,991 |
| 2026-06-23 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −117,592 | $54.47 | $6.4M | 559,399 |
| 2026-05-06 | Hite Christopher EVP & Vice Chairman | Grant or award | +24,263 | 709,399 | ||
| 2026-02-11 | Hite Christopher EVP & Vice Chairman | Grant or award | +26,626 | 685,136 | ||
| 2025-11-05 | Hite Christopher EVP & Vice Chairman | Grant or award | +6,168 | 658,510 | ||
| 2025-08-06 | Hite Christopher EVP & Vice Chairman | Grant or award | +3,696 | 652,342 | ||
| 2025-05-16 | Hite Christopher EVP & Vice Chairman | Grant or award · Class E Ordinary Shares | +1,238,789 | 1,238,789 | ||
| 2025-05-08 | Hite Christopher EVP & Vice Chairman | Grant or award | +48,646 | 648,646 |
Page 1 of 1 · 18 trades